10th Sep 2010 16:04
RNS Number : 5226S
GlaxoSmithKline PLC
10 September 2010
Directorate Change
Further to the announcement made on 8 September 2010 regarding the appointment of Simon Dingemans as Executive Director and Chief Financial Officer Designate with effect from 4 January 2011, the Company confirms that there are no further disclosures to be made in accordance with Listing Rule 9.6.13R.
S M Bicknell
Company Secretary
10 September 2010
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Glaxosmithkline